How do hyperosmolar hyperglycemic state (HHS) and diabetic ketoacidosis (DKA) differ regarding typical patient profile, pathophysiology, clinical presentation, laboratory findings, and management?

Differences Between HHS and DKA

HHS and DKA are distinct hyperglycemic crises that differ primarily in the degree of insulin deficiency: DKA results from absolute insulin deficiency causing severe ketoacidosis with moderate hyperglycemia, while HHS involves relative insulin deficiency with residual beta-cell function sufficient to prevent ketosis but inadequate to control severe hyperglycemia and hyperosmolarity. 1

Laboratory Findings: The Key Distinguishing Features

Glucose Levels

• DKA: Plasma glucose typically >250 mg/dL 1
• HHS: Markedly elevated glucose, usually >600 mg/dL 1

Acid-Base Status (Most Critical Distinction)

• DKA: Arterial pH ranges from <7.00 to 7.25-7.30, with serum bicarbonate from <10 mEq/L to 15-18 mEq/L 1
• HHS: Arterial pH typically >7.30, with serum bicarbonate typically >15 mEq/L 1

Ketone Bodies (Defining Feature)

• DKA: Positive serum and urine ketones 1
• HHS: Small or absent ketones in serum and urine 1

Osmolality

• HHS: Effective serum osmolality >320 mOsm/kg, calculated as 2[measured Na+ (mEq/L)] + glucose (mg/dL)/18 1
• DKA: Variable osmolality, typically less severe 1

Anion Gap

• DKA: Elevated anion gap (>10-12 mEq/L) 1
• HHS: Variable anion gap 1

Clinical Presentation Differences

Time Course of Development

• DKA: Develops rapidly, typically within 24 hours 1
• HHS: Evolves slowly over several days to weeks 1

Neurological Status

• DKA: Mental status ranges from alert to stupor/coma 1
• HHS: More frequently presents with stupor/coma due to severe hyperosmolarity 1

Physical Findings

• DKA: Kussmaul respirations (deep, rapid breathing to compensate for acidosis), abdominal pain and vomiting common 1
• HHS: More profound dehydration, less common abdominal pain, no Kussmaul respirations 1

Shared Symptoms

Both conditions present with polyuria, polydipsia, polyphagia, weight loss, dehydration, and weakness 1

Pathophysiology: Why the Differences Exist

DKA Mechanism

• Absolute insulin deficiency combined with elevated counterregulatory hormones (glucagon, catecholamines, cortisol, growth hormone) 2
• Triggers uncontrolled lipolysis, releasing free fatty acids from adipose tissue 3
• Hepatic beta-oxidation of fatty acids generates excess ketone bodies (acetoacetate, beta-hydroxybutyrate, acetone), causing metabolic acidosis 3

HHS Mechanism

• Relative insulin deficiency with residual beta-cell function 1
• Residual insulin action is sufficient to prevent significant lipolysis and ketogenesis but inadequate to control hyperglycemia 1, 2
• More severe osmotic diuresis leads to profound dehydration and hyperosmolarity 4

Typical Patient Profiles

DKA

• More common in younger patients with type 1 diabetes 5
• Approximately 25% of newly diagnosed type 1 diabetes patients present in DKA 3
• Can occur in type 2 diabetes with acute stressors (infection, SGLT2 inhibitors) 3

HHS

• Predominantly affects adult and elderly patients with type 2 diabetes 5
• Elderly individuals in chronic care facilities who become hyperglycemic and unable to access fluids are at particular risk 6
• Often the first manifestation of previously undiagnosed type 2 diabetes 4

Common Precipitating Factors (Similar for Both)

Infection is the single most common precipitating factor for both DKA and HHS, accounting for 30-50% of cases 3, with urinary tract infections and pneumonia being predominant 3

Other Shared Triggers

• Myocardial infarction 3
• Cerebrovascular accident 6
• Acute pancreatitis 6
• Trauma 6
• Medications: corticosteroids, thiazides, sympathomimetic agents (dobutamine, terbutaline) 6

DKA-Specific Triggers

• Insulin omission or inadequate dosing in established type 1 diabetes 6
• SGLT2 inhibitors (including euglycemic DKA) 3
• Insulin pump failure or disconnection 3

Fluid and Electrolyte Deficits

Total Body Deficits

• DKA: Total water deficit ~6 liters, Na 100 mEq/kg, K 3-5 mEq/kg 6
• HHS: Total water deficit ~9 liters, Na 100-200 mEq/kg, K 5-15 mEq/kg 6

HHS requires more aggressive fluid replacement due to greater total body deficits 1

Management Differences

Initial Fluid Therapy (Similar Approach)

Both conditions require isotonic saline (0.9% NaCl) at 15-20 mL/kg/hr during the first hour 6, 1

Key Management Distinctions

• DKA: Insulin therapy is the cornerstone of treatment 7
• HHS: Fluid replacement is the cornerstone of therapy 7
• DKA: Bicarbonate therapy may be required in severe cases (pH <7.0) 1
• HHS: Bicarbonate therapy rarely needed 1

Mixed Cases

Approximately one-third of patients may have mixed features of both DKA and HHS 7. These cases are managed using the same three-pronged approach (fluids, insulin, electrolytes), with therapy tailored to the prominent clinical features 7

Mortality Risk

HHS carries a significantly higher mortality rate (15%) compared to DKA (5% in experienced centers) 1

Poor Prognostic Factors (Both Conditions)

• Extremes of age (>65 years) 1, 2
• Presence of coma 1
• Hypotension 1
• Hypothermia (if present, indicates poor prognosis) 6

Critical Pitfalls to Avoid

Temperature Unreliability

Patients with infection-related DKA or HHS can be normothermic or even hypothermic despite serious infection; hypothermia is actually a poor prognostic sign 6, 3. Do not rely on fever to diagnose infection 6

Abdominal Pain in DKA

Abdominal pain can be either a cause or consequence of DKA 6. If abdominal pain does not resolve with standard DKA treatment, further evaluation for acute abdominal pathology is necessary 6

Failure to Identify Precipitating Cause

The most common pitfall is failing to identify and treat the underlying precipitating cause, most commonly infection 1. Obtain bacterial cultures (blood, urine, throat) and initiate appropriate antibiotics empirically if infection is suspected 6

Cerebral Edema Risk

In younger patients with mixed DKA/HHS features, avoid rapid correction of metabolic abnormalities and hyperosmolarity with hypotonic fluids and insulin to decrease cerebral edema risk 7. In adults, this risk is low, and undertreatment carries greater consequences (vascular occlusion, increased mortality) 7